← Evidence map

ReviewTherapeutic advances in medical oncology2016

Neratinib in HER-2-positive breast cancer: results to date and clinical usefulness.

Arlene ChanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

22 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27583026